Prevalence and risk factors of CIN2+ in high risk HPV other than HPV 16/18 women in Colposcopic clinic, Srinagarind Hospital

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20250827004

Enrollment

129

Registered

2025-08-27

Start date

2025-09-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-16/18 high-risk human papilloma virus (hr-HPV) positive Non-16/18 hr-HPV positive Cervical intraepithelial neoplasia Cervical cancer

Interventions

High risk HPV other than HPV 16/18 women

Diagnostic

Eligibility

Sex/Gender

Female

Age

21 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. High risk HPV other than HPV 16/18 infection 2. Colposcopic examination 3. Colposcopically pathological examination

Exclusion criteria

Exclusion criteria: 1. Multiple HPV infection include type 16/18 2. No Colposcopically pathological examination 3. Previous RT or CMT

Design outcomes

Primary

Measure	Time frame
Prevalence of CIN2+ in non-16/18 hr-HPV positive At colposcopy was done. Percentage	—

Secondary

Measure	Time frame
Associated factors in the presence of CIN2+ with non 16/18 hr HPV positive At colposcopy was done. Percentage	—

Countries

Thailand

Contacts

Public ContactAriyaporn Kaewwiengdech

Faculty of Medicine, Khonkean University

Ariyka@kku.ac.th043363030

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026